Enzymes for Industrial Applications

Stephan Lütz, Novartis

 

 

"Enzymes haven become first choice for certain syntheses, e.g. of chiral alcohols or amines, and there are many other opportunities still out there." 

 

Wed 4 Feb 2015, 15:00:

Applications of biocatalysis in drug discovery

  • synthesis of chiral building blocks with isolated enzymes
  • expanding the enzyme toolbox for metabolite synthesis
  • biocatalysis for natural products

 

CV:

  • 2013: Habilitation (venia docendi) in biochemistry, Biozentrum, University of Basel
  • 2009: Group Leader and Manager for Bioreactions, Novartis Pharma AG, Basel
  • 2004: Ph.D. in chemistry, Institute of Biotechnology, Forschungszentrum Jülich
  • 2000: diploma in chemistry / technical chemistry, University of Bonn

 

 

 

 

 

 

 

 

CONTACT US:

Mathes_DECHEMA_small

Dr. Björn Mathes
Head of PRAXISforums

Phone +49 69 7564-365
Fax +49 69 7564-117
E-Mail:

DECHEMA e.V.
Theodor-Heuss-Allee 25
D-60486 Frankfurt am Main
Germany

Events
Become a member